Joshua Jacobs to Immunotherapy
This is a "connection" page, showing publications Joshua Jacobs has written about Immunotherapy.
Connection Strength
0.153
-
Long-term Safety and Efficacy of Reslizumab in Patients with Eosinophilic Asthma. J Allergy Clin Immunol Pract. 2017 Nov - Dec; 5(6):1572-1581.e3.
Score: 0.153
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.